EEG frequency bands in psychiatric disorders: a review of resting state studies
JJ Newson, TC Thiagarajan - Frontiers in human neuroscience, 2019 - frontiersin.org
A significant proportion of the electroencephalography (EEG) literature focuses on
differences in historically pre-defined frequency bands in the power spectrum that are …
differences in historically pre-defined frequency bands in the power spectrum that are …
Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatry
Transcranial alternating current stimulation (tACS) is a unique form of non-invasive brain
stimulation. Sinusoidal alternating electric currents are delivered to the scalp to affect mostly …
stimulation. Sinusoidal alternating electric currents are delivered to the scalp to affect mostly …
Developmental timing and critical windows for the treatment of psychiatric disorders
O Marín - Nature medicine, 2016 - nature.com
There is a growing understanding that pathological genetic variation and environmental
insults during sensitive periods in brain development have long-term consequences on …
insults during sensitive periods in brain development have long-term consequences on …
Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia
Cognitive deficits are a core clinical feature of schizophrenia but respond poorly to available
medications. Thus, understanding the neural basis of these deficits is crucial for the …
medications. Thus, understanding the neural basis of these deficits is crucial for the …
EEG-based measures in at-risk mental state and early stages of schizophrenia: a systematic review
A Perrottelli, GM Giordano, F Brando, L Giuliani… - Frontiers in …, 2021 - frontiersin.org
Introduction: Electrophysiological (EEG) abnormalities in subjects with schizophrenia have
been largely reported. In the last decades, research has shifted to the identification of …
been largely reported. In the last decades, research has shifted to the identification of …
NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
D Cadinu, B Grayson, G Podda, MK Harte… - …, 2018 - Elsevier
Negative and cognitive deficit symptoms in schizophrenia remain an unmet clinical need.
Improved understanding of the neuro-and psychopathology of cognitive dysfunction in the …
Improved understanding of the neuro-and psychopathology of cognitive dysfunction in the …
Abnormal asymmetry of brain connectivity in schizophrenia
M Ribolsi, ZJ Daskalakis, A Siracusano… - Frontiers in human …, 2014 - frontiersin.org
Recently, a growing body of data has revealed that beyond a dysfunction of connectivity
among different brain areas in schizophrenia patients (SCZ), there is also an abnormal …
among different brain areas in schizophrenia patients (SCZ), there is also an abnormal …
[HTML][HTML] A quantitative review of the postmortem evidence for decreased cortical N-methyl-D-aspartate receptor expression levels in schizophrenia: How can we link …
Evidence suggests that anomalous mismatch negativity (MMN) in schizophrenia is related to
glutamatergic abnormalities, possibly involving N-methyl-d-aspartate (NMDA) receptors …
glutamatergic abnormalities, possibly involving N-methyl-d-aspartate (NMDA) receptors …
How do abnormalities in the brain's spontaneous activity translate into symptoms in schizophrenia? From an overview of resting state activity findings to a proposed …
Schizophrenia is a complex neuropsychiatric disorder with a variety of symptoms that
include sensorimotor, affective, cognitive, and social changes. The exact neuronal …
include sensorimotor, affective, cognitive, and social changes. The exact neuronal …
Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages
We examined alterations in E/I-balance in schizophrenia (ScZ) through measurements of
resting-state gamma-band activity in participants meeting clinical high-risk (CHR) criteria (n …
resting-state gamma-band activity in participants meeting clinical high-risk (CHR) criteria (n …